Literature DB >> 30112691

Prognostic Factors of Extramammary Paget's Disease.

Naohito Hatta1.   

Abstract

OPINION STATEMENT: Most patients with extramammary Paget's disease (EMPD) show a good prognosis; however, some patients develop fatal metastases. Early detection is important for improving prognosis, due to the difficulties associated with the treatment of distant EMPD metastases. Several studies have emphasized the importance of the invasion level of the primary lesion for predicting the presence of metastasis, and deeper invasion or increased thickness is correlated with poorer prognosis. Vascular tumor invasion of the primary lesion can also predict the risk of metastasis. Lymph node metastasis is a strong indicator for poor prognosis, and the number of lymph node metastases affects patient outcome, in that there is a significant difference in survival between patients with zero or one lymph node metastasis and those with more than two lymph node metastases. Serum markers may be able to predict the presence of systemic metastases, and carcinoembryonic antigen and cytokeratin 19 fragment 21-1 reflect disease progression and may be clinically valuable. Although several genetic alterations have been determined for EMPD, factors determining prognosis should be further explored.

Entities:  

Keywords:  Genitalia; Invasion; Lymph node; Metastasis; Serum marker

Mesh:

Substances:

Year:  2018        PMID: 30112691     DOI: 10.1007/s11864-018-0567-4

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  55 in total

1.  Usefulness of sentinel lymph node biopsy for extramammary Paget disease.

Authors:  Y Nakamura; Y Fujisawa; M Ishikawa; Y Nakamura; Y Ishitsuka; H Maruyama; J Furuta; Y Kawachi; F Otsuka
Journal:  Br J Dermatol       Date:  2012-07-19       Impact factor: 9.302

2.  Stop routine screening for associated malignancies in cutaneous noninvasive vulvar Paget disease?

Authors:  M van der Linden; M S Schuurman; J Bulten; L F A G Massuger; J IntHout; M A van der Aa; J A de Hullu
Journal:  Br J Dermatol       Date:  2018-09-09       Impact factor: 9.302

3.  Treatment outcomes in a large cohort of patients with invasive Extramammary Paget's disease.

Authors:  Amer Karam; Oliver Dorigo
Journal:  Gynecol Oncol       Date:  2012-01-28       Impact factor: 5.482

4.  Vulvar Paget's disease: the need to exclude an invasive lesion.

Authors:  G A Feuer; M Shevchuk; A Calanog
Journal:  Gynecol Oncol       Date:  1990-07       Impact factor: 5.482

5.  erbB-2 overexpression but no activation of beta-Catenin gene in extramammary Paget's disease.

Authors:  M Takata; A Fujimoto; H Aoki; N Hatta; A Ooi; K Takehara
Journal:  J Invest Dermatol       Date:  1999-08       Impact factor: 8.551

Review 6.  Risk stratification in extramammary Paget disease.

Authors:  J M Cohen; S R Granter; A E Werchniak
Journal:  Clin Exp Dermatol       Date:  2015-05-26       Impact factor: 3.470

7.  PI3K, Rac1 and pPAK1 are overexpressed in extramammary Paget's disease.

Authors:  Yue Qian; Na Zhang; Siyuan Chen; Shujuan Chu; Aiping Feng; Houjun Liu
Journal:  J Cutan Pathol       Date:  2012-07-28       Impact factor: 1.587

8.  Extramammary Paget's disease in Korea: its association with gastrointestinal neoplasms.

Authors:  Sang Nam Yoon; In Ja Park; Hee Cheol Kim; Chang Sik Yu; Mi Woo Lee; Jai Kyoung Koh; Jin Wou Kim; Young Soo Park; Jin Cheon Kim
Journal:  Int J Colorectal Dis       Date:  2008-06-06       Impact factor: 2.571

9.  Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget's disease.

Authors:  Y Zhu; D W Ye; X D Yao; S L Zhang; B Dai; H L Zhang; Y J Shen; H R Mao
Journal:  Br J Dermatol       Date:  2009-04-29       Impact factor: 9.302

10.  Mammary and extramammary Paget's disease: an immunohistochemical study of 83 cases.

Authors:  B Liegl; S Leibl; M Gogg-Kamerer; B Tessaro; L-C Horn; F Moinfar
Journal:  Histopathology       Date:  2007-03       Impact factor: 5.087

View more
  2 in total

Review 1.  A primer on extramammary Paget's disease for the urologist.

Authors:  Joon Yau Leong; Paul H Chung
Journal:  Transl Androl Urol       Date:  2020-02

2.  Response to Pyrotinib in a Chinese Patient with Bone-Metastatic Scrotal Paget's Disease Harboring Triple Uncommon HER2 Mutation: A Case Report.

Authors:  Jin-Ju Guo; Xiao-Dong Jiao; Ying Wu; Bao-Dong Qin; Ke Liu; Yuan-Sheng Zang
Journal:  Onco Targets Ther       Date:  2020-06-30       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.